A Maryland truck driver suffered an “eye stroke” that left him blind, first in one eye and then the other. A Louisiana woman vomited for weeks before being diagnosed with a brain dysfunction typically ...

Retatrutide shows highest weight loss to date in trial Lilly says trial departures due to perceived excessive weight loss Retatrutide shows elevated skin-related side effects Dec 11 (Reuters) - Eli ...

Amy Schumer, 44, has wowed fans with a 30-lb weight loss via Mounjaro after Ozempic didn’t work, while rumors question whether her marriage is ending. Suspected Brown University gunman found dead ...

A new study found that when people came off the GLP-1 tirzepatide (Zepbound), they regained at least 25 percent of their lost weight after about a year. Those who regained more weight experienced ...

Danish researchers were examining the use of medications during and after pregnancy when they noticed a clear trend: The number of women using weight-loss drugs like Ozempic and Wegovy soon after ...

In 2025, the average annual premium for family health coverage reached $26,993, an increase of $1,408 (6 percent) from the previous year. Covered workers contributed an average of 16 percent ($1,440) ...

There are various types of body composition tests (more on these below). Still, each one measures the percentages of fat and fat-free mass (muscle and bone) in the body. Knowing these percentages can ...

Rejoice, netizens of flesh and blood, for only a little over half of all new articles on the internet are AI-generated, according to a new report highlighted in Axios. Believe it or not, this is kind ...

One bantamweight’s UFC future is in doubt after he came in closer to the featherweight limit. There’s been drama one day out from UFC Rio after one athlete set to compete on Saturday night almost ...

Become a Vogue Business Member to receive unlimited access to Member-only reporting and insights, our Beauty and TikTok Trend Trackers, Member-only newsletters and exclusive event invitations.

The treatment, known as CagriSema, combines two hormone-based drugs — semaglutide, already approved for weight loss, and cagrilintide, which is still being studied. Cagrilintide is a long-acting form ...